type full_text History And Physical Findings [REDACTED][REDACTED] [REDACTED_PASSPORT] 84/ Chinese/ female ADL independent, community ambulant Lives with youngest sonNon smoker, non drinker DA: Acarbose Past Medical History 1. T 2 DM with DM nephropathy HbA1c (2/5/19): 9.0 2. HTN 3. HLD 4. IHD 5. Autoimmune hepatitis Liver biopsy (16/7/09): Features in keeping with a lobular hepatitis with confluent necrosis and bridging fibrosis. Differential diagnosis includes autoimmune hepatitis. A drug or infectious related etiology should be excluded. ANA 1/400, Anti SMA amp gt 1/400 Hep B/C negative Cardiac History Hx of NSTEMI (2008) Coros (Feb 2008): Mid to distal LM 90 , pLAD 25 , ostium D 1 75 , mid RCA 75 s/p CABG x 3 (Feb 2008, LIMA LAD, SCG OM 1, SVG RPDA) dipMIBI (2008) Moderate size partially reeversible defect involving the LAD territory consistent with infarction with minimal peri infarct ischaemia, LVEF 57 at rest by gating 2 D Echo (16/10/13): LVEF 35 . RWMA consistent with IHD (multi vessel territory). Grade 1 diastolic dysfunction. Last admitted 15/4 16/4/19 to RAI for(i) Diaphoresis atypical presentation likely angina equivalent Dip MIBI (17/4/19):1. Small apical anteroseptal full thickness infarct.2. Small full thickness infarct in the apex extending to the apical lateral segment.3. Mildly dilated left ventricle with moderately depressed left ventricular function with regional wall motionabnormalities as described above.4. Suggest continue medical therapy and risk factor control unless dictated by symptoms(ii) AoCKD sec dehydration/volume depletion amp gt lasix 40 mg OM stopped (iii) Traction bronchiectasis Chronic Medications Aspirin 100 mg OMOmeprazole 20 mg OMBisoprolol 5 mg OMGliclazide MR 120 mg OMLinagliptin 5 mg OMAtorvastatin 10 mg OMCarbimazole 2.5 mg 3 x/week (M, W,F)ISMN 30 mg oMCalcium and Vit D 1 tab OMNeurobion 1 tab OMAzathioprine 25 mg OMS/L GTN Current Admission SOB x 2/7 associated with exertional dyspnoea/ orthopnoea/ LL swelling denies chest pain/ palpitations no coryzal symptoms no bleeding manifestation On Examination Afebrile BP 162/67 HR 68 SpO2 97 RAAlert, comfortable, not in respiratory distressH S 1 S 2 L bibasal crepitationsA SNT BS Calves supple, pitting oedema to mid shins Initial Investigations WCC 6.8 Hb 9.5 plt 152 Na 143 K 4.4 Cr 134 U 10.8 BNP 2470 troponin 15 amp gt 14 H/C 11.3 ECG NSR, LVH, no acute changesCXR bibasal opacities Progress in ED Given IV Lasix 40 mg once Issues and Progress 1. ADHF ppt by lasix withdrawal and poorly controlled HTN b/g IHD, recent DIP MIBI [17/4/19] EF 38 , for medical therapy baseline PO frusemide 40 mg BD baseline Cr 150 s dry weight 46 kg started on IV Lasix 40 mg BD with good diuresis effect then oralised to 60 mg BD subsequently reduced frusemide back to baseline 40 mg BD upon discharge PO frusemide 40 mg BD weight 46 Cr 142 2. NCNC anemia Baseline Hb 12 on admission 9.5 amp gt 9.8 ?haemodilution amp gt 10.4 Iron 11 Ferritin 73 Iron sat 23 IV Ferinject 1 g given on 11/5/19 Medication Changes Off bisoprolol , switched to carvedilol 25 mg BD Patient discharged well and hemodynamically stable on 13/5/19 Plans TCU HFC 22/5/19 old date OPS 24/7/19 old date SGH Gastro 1/10/19 old date SNEC 30/10/19 old date ENT 21/2/19 old date Outcome Followup Plan TCU HFC 22/5/19 old date OPS 24/7/19 old date SGH Gastro 1/10/19 old date SNEC 30/10/19 old date ENT 21/2/19 old date